ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 87 | +112.2% | 0.00% | – |
| Q2 2022 | $0 | – | 41 | -93.4% | 0.00% | – |
| Q1 2022 | $0 | – | 622 | +1417.1% | 0.00% | – |
| Q4 2021 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 41 | -96.9% | 0.00% | – |
| Q2 2021 | $3,000 | -98.7% | 1,313 | -98.2% | 0.00% | – |
| Q1 2021 | $239,000 | -14.0% | 72,109 | +3.4% | 0.00% | – |
| Q4 2020 | $278,000 | +1012.0% | 69,725 | +599.8% | 0.00% | – |
| Q3 2020 | $25,000 | -7.4% | 9,963 | +10.8% | 0.00% | – |
| Q2 2020 | $27,000 | +68.8% | 8,992 | +11.5% | 0.00% | – |
| Q1 2020 | $16,000 | -73.8% | 8,068 | -2.3% | 0.00% | – |
| Q4 2019 | $61,000 | +64.9% | 8,261 | +0.2% | 0.00% | – |
| Q3 2019 | $37,000 | -40.3% | 8,248 | +32.3% | 0.00% | – |
| Q2 2019 | $62,000 | -3.1% | 6,233 | +13.9% | 0.00% | – |
| Q1 2019 | $64,000 | -7.2% | 5,472 | -4.5% | 0.00% | – |
| Q4 2018 | $69,000 | -22.5% | 5,728 | +10.3% | 0.00% | – |
| Q3 2018 | $89,000 | +3.5% | 5,195 | +4.2% | 0.00% | – |
| Q2 2018 | $86,000 | – | 4,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,950,949 | $1,092,000 | 0.45% |
| AMERICAN FINANCIAL GROUP INC | 1,480,000 | $829,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 158,900 | $86,000 | 0.06% |
| Atom Investors LP | 113,151 | $63,000 | 0.03% |
| Nantahala Capital Management | 774,767 | $434,000 | 0.02% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,173,000 | 0.02% |
| Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $659,000 | 0.01% |
| Altshuler Shaham Ltd | 1,088,848 | $609,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 309,400 | $173,000 | 0.00% |
| Clal Insurance Enterprises Holdings Ltd | 585,000 | $328,000 | 0.00% |